ArticleJournal of robotic surgery2025
Machine learning-based prediction of post-operative outcomes in robotic-assisted radical prostatectomy: a multi-variable analysis of 758 cases.
Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and multicohort external validation of a preoperative [18F]PSMA-1007 PET-derived deep learning score and multimodal model for predicting biochemical recurrence-free survival after radical prostatectomy.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robotic-assisted radical prostatectomy (RARP) has become the gold standard treatment for localized prostate cancer. However, predicting post-operative outcomes remains challenging. This study aims to develop and validate predictive models for key outcomes using machine learning approaches and compare them with traditional risk stratification systems. We conducted a retrospective analysis of 758 consecutive patients who underwent RARP between 2014 and 2018. Pre-operative variables included PSA, Gleason score, clinical stage, and IPSS scores. Primary outcomes were biochemical recurrence (BCR), positive surgical margins (PSM) (PSM), and functional outcomes at 12 months. Machine learning algorithms were compared with D'Amico and CAPRA risk stratification systems. The cohort included 758 patients with a mean age of 60.5 years. At 12-month follow-up (n = 634), biochemical recurrence rate was 4.5% (29/634). For pre-operative counseling applications, the machine learning model using only pre-surgical variables achieved AUC 0.783 for predicting 12-month biochemical recurrence, significantly outperforming D'Amico classification (AUC 0.692, p < 0.001). The comprehensive post-operative model incorporating pathological variables achieved optimal performance (AUC 0.847 for 12-month BCR, AUC 0.863 for 24-month BCR). At 12-month follow-up, biochemical recurrence occurred in 4.5% (34/753) of patients. Key pre-operative predictors included PSA (OR 1.23 per ng/mL, 95% CI 1.15-1.31), biopsy Gleason score ≥ 8 (OR 3.45, 95% CI 2.18-5.46), and clinical stage ≥ T2b (OR 2.67, 95% CI 1.89-3.77). Machine learning-based prediction models significantly outperform traditional risk stratification systems for predicting post-operative outcomes in RARP. These models provide personalized risk assessment to guide treatment decisions and patient counseling.
Indexed as
Identifiers
40999210What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.